Urologist sentenced for practicing without a license

A urologist who treated 65 patients after his license was suspended last November because he posed "a substantial danger to public health and safety" was ordered to spend 4 months in jail and pay a $10,000 fine.

Related Videos

Related Content

Advertisement

July 8th 2025

UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC

Benjamin P. Saylor Hannah Clarke

According to the company, the MHRA approval represents the first marketing approval outside the US for NAI.

June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD

Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.

July 8th 2025

Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC

Hannah Clarke

The data, collected as part of the phase 1/2 Duravelo-1 trial, showed an objective response rate of 65%.

June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD

The conversation covers practical, case-based strategies for counseling MSM patients.

July 7th 2025

Expanded indication sought for niraparib plus AAP in Europe

Hannah Clarke

The application is supported by data from the phase 3 AMPLITUDE trial.

July 4th 2025

Regulatory recap: FDA approvals in urology from the first half of 2025

Hannah Clarke

Take a look through all the regulatory milestones in urology from the first half of the 2025.

Related Content

Advertisement

July 8th 2025

UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC

Benjamin P. Saylor Hannah Clarke

According to the company, the MHRA approval represents the first marketing approval outside the US for NAI.

June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD

Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.

July 8th 2025

Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC

Hannah Clarke

The data, collected as part of the phase 1/2 Duravelo-1 trial, showed an objective response rate of 65%.

June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD

The conversation covers practical, case-based strategies for counseling MSM patients.

July 7th 2025

Expanded indication sought for niraparib plus AAP in Europe

Hannah Clarke

The application is supported by data from the phase 3 AMPLITUDE trial.

July 4th 2025

Regulatory recap: FDA approvals in urology from the first half of 2025

Hannah Clarke

Take a look through all the regulatory milestones in urology from the first half of the 2025.